Stock PDLI PDL BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders PDL BioPharma, Inc.

Equities

PDLI

US69329Y1047

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
David W. Gryska to Resign as Member of the Board of Directors and Committee of PDL BioPharma, Inc., Effective December 31, 2020
CI
PDL BioPharma, Inc. Announces the Resignation of Shlomo Yanai from the Board of Directors
CI
PDL Biopharma, Inc. Appoints Edward A. Imbrogno as the Vice President and Chief Financial Officer
CI
PDL BioPharma, Inc. Appoints Alan L. Bazaar as Class III Director and Committee Member
CI
PDL BioPharma, Inc. Announces Board and Committee Changes
CI
PDL BioPharma, Inc. Announces Executive Changes
CI
PDL BioPharma, Inc. Announces resignation of Samuel R. Saks as a Member of the Board of Directors
CI
PDL BioPharma, Inc. Announces Resignation of Peter Garcia as Vice President and Chief Financial Officer, Effective as of August 15, 2019
CI
PDL BioPharma, Inc. Announces Management Appointments
CI
PDL BioPharma, Inc. Announces Resignation of Paul Edick as Member of the Board of Directors, Effective December 31, 2018
CI
PDL BioPharma, Inc. Announces Management Changes, Effective on December 31, 2018
CI
PDL BioPharma, Inc. Names Edward Imbrogno as Vice President of Finance
CI
PDL BioPharma, Inc. Announces Resignation of Jody Lindell as a Member of the Board of Directors
CI
PDL BioPharma : Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors
PU
PDL BioPharma, Inc. Appoints Elizabeth G. O'farrell as a Class I Director and as a Member of the Board's Audit Committee
CI
PDL BioPharma, Inc. Elects Shlomo Yanai to the Board of Directors
CI
PDL BioPharma, Inc. Appoints Jill M. Jene, Ph.D. as Vice President, Business Development
CI
PDL BioPharma : Shareholder, SevenSaoi Capital, Comments on the Nomination of Shlomo Yanai to the PDL Board of Directors and Delivers Letter to the Board Outlining Significant Concerns
PR
Steffen Pietzke Tenders Resignation to PDL BioPharma, Inc. as Vice President, Finance and Chief Accounting Officer, Effective as of April 17, 2018
CI
PDL BioPharma Discloses Nomination Notice from SevenSaoi Capital
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PDLI Stock
  4. News PDL BioPharma, Inc.
  5. Insiders